BioMarin (BMRN) is up 21.4%, or $11.13 to $63.08.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRN:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
- BioMarin rises 16.7%
- BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
- BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio